These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer]. Honguero Martínez AF, Arnau Obrer A, Figueroa Almazán S, Martínez Hernández N, Guijarro Jorge R. Med Clin (Barc); 2014 May 20; 142(10):432-7. PubMed ID: 23948151 [Abstract] [Full Text] [Related]
29. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer. Zhang J, Wu Y, Lin YH, Guo S, Ning PF, Zheng ZC, Wang Y, Zhao Y. World J Gastroenterol; 2018 Jun 14; 24(22):2381-2391. PubMed ID: 29904245 [Abstract] [Full Text] [Related]
31. Hypoxia-inducible factor 1α polymorphisms and early-stage cervical cancer. Kim YH, Park IA, Park WY, Kim JW, Kim SC, Park NH, Song YS, Kang SB. Int J Gynecol Cancer; 2011 Jan 14; 21(1):2-7. PubMed ID: 21330825 [Abstract] [Full Text] [Related]
35. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis. Ren W, Mi D, Yang K, Cao N, Tian J, Li Z, Ma B. Swiss Med Wkly; 2013 Jan 14; 143():w13855. PubMed ID: 24018850 [Abstract] [Full Text] [Related]
37. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM, Stratford IJ. Int J Cancer; 2003 Mar 10; 104(1):85-91. PubMed ID: 12532423 [Abstract] [Full Text] [Related]
38. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H, Haensgen G. Int J Radiat Oncol Biol Phys; 2003 Jul 01; 56(3):778-87. PubMed ID: 12788185 [Abstract] [Full Text] [Related]
39. Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer. Viswanathan AN, Cormack R, Rawal B, Lee H. Int J Gynecol Cancer; 2009 Nov 01; 19(8):1402-6. PubMed ID: 20009897 [Abstract] [Full Text] [Related]